Items where Author is "Nagarajan, D"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

Journal article

ALMSHAYAKHCHI, R., NAGARAJAN, D., VADAKEKOLATHU, J., GUINN, B.-A., REEDER, S., BRENTVILLE, V., METHERINGHAM, R., POCKLEY, A.G., DURRANT, L. and MCARDLE, S., 2021. A novel HAGE/WT1-ImmunoBody® vaccine combination enhances anti-tumour responses when compared to either vaccine alone. Frontiers in Oncology, 11: 636977.

NAGARAJAN, D., PEARSON, J., BRENTVILLE, V., METHERINGHAM, R., POCKLEY, A.G., DURRANT, L. and MCARDLE, S.E., 2021. ImmunoBody®‐HAGE derived vaccine induces immunity to HAGE and delays the growth and metastasis of HAGE‐expressing tumours in vivo. Immunology and Cell Biology. ISSN 0818-9641

CUZZUBBO, S., MANGSBO, S., NAGARAJAN, D., HABRA, K., POCKLEY, A.G. and MCARDLE, S.E.B., 2021. Cancer vaccines: adjuvant potency, importance of age, lifestyle, and treatments. Frontiers in Immunology, 11: 615240. ISSN 1664-3224

FOULDS, G.A., VADAKEKOLATHU, J., ABDEL-FATAH, T.M.A., NAGARAJAN, D., REEDER, S., JOHNSON, C., HOOD, S., MOSELEY, P.M., CHAN, S.Y.T., POCKLEY, A.G., RUTELLA, S. and MCARDLE, S.E.B., 2018. Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts relapse of triple negative breast cancer. Frontiers in Immunology, 9: 2028. ISSN 1664-3224

Thesis

NAGARAJAN, D., 2018. Towards the development of HAGE-based vaccines for the treatment of patients with triple negative breast cancers. PhD, Nottingham Trent University.

This list was generated on Wed Oct 20 11:19:39 2021 UTC.